<DOC>
	<DOCNO>NCT02778100</DOCNO>
	<brief_summary>The main purpose study evaluate safety LY900018 participant common cold , also take nasal decongestant . The study investigate body process LY900018 effect LY900018 body . The study last 30 day participant .</brief_summary>
	<brief_title>A Study LY900018 Participants With Common Cold</brief_title>
	<detailed_description />
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<criteria>Male female participant present score 2 3 nasal congestion and/or nasal discharge associate least one symptom common cold , determine 8item Jackson cold scale screen prior dose period 1 . Participant body mass index ( BMI ) great equal 18.50 30.00 kg/mÂ² . Light , non exsmokers . Have clinically significant disease capture medical history evidence clinically significant finding physical examination and/or clinical laboratory evaluation ( hematology , biochemistry , ECG urinalysis ) . Presence nose piercings . History significant hypersensitivity glucagon , oxymetazoline relate product ( include excipients formulation ) well severe hypersensitivity reaction ( like angioedema ) drug . Presence significant gastrointestinal , liver kidney disease , condition know interfere absorption , distribution , metabolism excretion drug know potentiate predispose undesired effect . Presence significant cardiovascular , pulmonary , hematologic , neurological , psychiatric , endocrine , immunologic dermatologic disease . Presence severe fever ( 39.5 degree Celsius ) screen prior dose period 1 . Presence clinically significant finding nasal examination bilateral anterior rhinoscopy , structural abnormality , nasal polyp , mark septal deviation , nasal tumor . Presence history Type 1 Type 2 diabetes . Presence history significant hypoglycemia hyperglycemia . Use betablockers , indomethacin , warfarin anticholinergic drug previous 28 day day 1 study . Fasting blood glucose 6.1 mmol/L screening , follow 12hour fasting period . Fasting blood glucose assess glucose meter 6.1 mmol/L approximately 0.5 hour dosing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>